ArticleTransplantation and cellular therapy2021

Planned Granulocyte Colony-Stimulating Factor Adversely Impacts Survival after Allogeneic Hematopoietic Cell Transplantation Performed with Thymoglobulin for Myeloid Malignancy.

Nina Orfali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.